首页 > 市场调查报告书 > 製药

个人化医学精神疾病

市场调查报告书

商品编码

1741512

个人化精神病学市场（按类型、治疗领域和地区）

Personalized Psychiatry Market, By Type, By Therapeutic Areas, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

个人化精神病学市场规模预计在 2025 年达到 50.8 亿美元，预计到 2032 年将达到 107.5 亿美元，2025 年至 2032 年的复合年增长率为 11.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	50.8亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	11.30%	2032年价值预测	107.5亿美元

个人化精神病学是精神卫生保健领域的新兴领域，旨在改变精神疾病的诊断和治疗方式。传统上，精神病学依赖「一刀切」的方法，即根据广泛的诊断标准为患者开药和治疗方法。个人化精神病学利用每位患者特有的基因、生物和临床数据，制定针对性的精神健康治疗方案。个人化精神病学旨在以更有针对性的客製化策略取代「一刀切」的策略。所使用的一些关键技术包括穿戴式生物感测器、电脑化治疗方案、定量脑电图、药物基因组学检测和分子诊断。社会对心理健康问题认识的不断提高、神经生物学和基因组学的发展以及对更好的心理健康诊断和治疗结果的需求是推动市场发展的主要因素。

市场动态：

个人化精神病学市场预计将在未来几年实现显着成长，这主要得益于以下几个关键因素：数位健康技术的快速发展、基因组学、穿戴式装置和行动应用程式的创新。此外，心理健康评估和治疗领域的人工智慧也有望在预测期内推动市场成长。这些技术能够即时收集数据，使临床医生能够远端监控患者并做出明智的护理决策。

然而，个人化精神医学市场也面临许多挑战。主要的限制因素之一是实施个人化治疗方案的高成本。先进技术的开发和实施成本高昂，而且这些服务的报销方案可能有限。此外，在精神健康保健中使用基因数位资料还存在监管和伦理问题，这可能会减缓个人化治疗方案的推广。

本研究的主要特点

本报告对全球个人化精神病学市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025 年至 2032 年的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球个人化精神病学市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球个人化精神病学市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球个人化精神病学市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.08 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 10.75 Bn

Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.

Market Dynamics:

The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.

However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.

Key features of the study:

This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized psychiatry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market

Detailed Segmentation:

By Type:
- Products
- Diagnostics
- Therapeutics
- Services
- Software
By Therapeutic Areas:
- Depression
- Anxiety
- Bipolar Disorder
- Schizophrenia
- Addiction
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GreyBird Ventures
- Sunovion Pharmaceuticals Inc.
- HMNC Holding GmbH
- Arcara Personalized Psychiatry
- Starling Minds
- Karuna Therapeutics
- CBT Plus
- AltheaDx, Inc.
- WayForward
- BrightQuest
- Peak Mental Wellness

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Psychiatry, By Type
- Market Personalized Psychiatry, By Therapeutic Areas
- Market Personalized Psychiatry, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing need for improved diagnosis and treatment outcomes in mental healthcare
- Rising prevalence of mental disorders
- Growing adoption of precision medicine model in healthcare
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Personalized Psychiatry Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Personalized Psychiatry Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostics
Therapeutics
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Personalized Psychiatry Market, By Therapeutic Areas, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bipolar Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Schizophrenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Personalized Psychiatry Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

GreyBird Ventures
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sunovion Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HBNC Holding GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arcara Personalized Psychiatry
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Starling Minds
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Karuna Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CBT Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AltheaDx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WayForward
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BrightQuest
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Peak Mental Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

个人化精神病学市场（按类型、治疗领域和地区）